[氯吡格雷。作用、药代动力学、临床研究] - Suppr

Suppr

超能文献

[Clopidogrel. Actions, pharmacokinetics, clinical studies].

作者信息

Wunderlich Helmut, Beer Jana, Allgaier Clemens

机构信息

Universität Leipzig, RBI für Pharmakolgie und Toxikologie, Härtelstrasse 16-18, 04107 Leipzig.

出版信息

Med Monatsschr Pharm. 2002 Dec;25(12):425-9.

PMID:12522913

Abstract

摘要

相似文献

[Clopidogrel. Actions, pharmacokinetics, clinical studies].

Med Monatsschr Pharm. 2002 Dec;25(12):425-9.

Variable platelet response to aspirin and clopidogrel in atherothrombotic disease.

Circulation. 2007 Apr 24;115(16):2196-207. doi: 10.1161/CIRCULATIONAHA.106.675991.

[Diagnosis, causes, relevance of a complex phenomenon. Resistance to aspirin and clopidogrel].

Pharm Unserer Zeit. 2009;38(4):342-50. doi: 10.1002/pauz.200900324.

P2Y12, a new platelet ADP receptor, target of clopidogrel.

Semin Vasc Med. 2003 May;3(2):113-22. doi: 10.1055/s-2003-40669.

P2Y receptor antagonists in thrombosis.

Curr Opin Investig Drugs. 2005 Mar;6(3):275-82.

Molecular basis of the clinical failure of Clopidogrel therapy.

Med Hypotheses. 2006;67(1):200-1. doi: 10.1016/j.mehy.2006.01.010. Epub 2006 Feb 28.

A double-blind, randomized study on platelet aggregation in patients treated with a daily dose of 150 or 75 mg of clopidogrel for 30 days.

Eur Heart J. 2007 Aug;28(15):1814-9. doi: 10.1093/eurheartj/ehl489. Epub 2007 Feb 1.

Clopidogrel resistance.

Heart Lung Circ. 2007;16 Suppl 3:S17-28. doi: 10.1016/j.hlc.2007.03.012. Epub 2007 Jul 3.

Evaluation of clopidogrel resistance.

Thromb Res. 2005;116(5):451-3. doi: 10.1016/j.thromres.2005.05.017.

Platelet response to clopidogrel is attenuated in diabetic patients undergoing coronary stent implantation.

Diabetes Care. 2007 Feb;30(2):372-4. doi: 10.2337/dc06-1625.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

[Clopidogrel. Actions, pharmacokinetics, clinical studies].

Med Monatsschr Pharm. 2002 Dec;25(12):425-9.

Variable platelet response to aspirin and clopidogrel in atherothrombotic disease.

Circulation. 2007 Apr 24;115(16):2196-207. doi: 10.1161/CIRCULATIONAHA.106.675991.

[Diagnosis, causes, relevance of a complex phenomenon. Resistance to aspirin and clopidogrel].

Pharm Unserer Zeit. 2009;38(4):342-50. doi: 10.1002/pauz.200900324.

P2Y12, a new platelet ADP receptor, target of clopidogrel.

Semin Vasc Med. 2003 May;3(2):113-22. doi: 10.1055/s-2003-40669.

P2Y receptor antagonists in thrombosis.

Curr Opin Investig Drugs. 2005 Mar;6(3):275-82.

Molecular basis of the clinical failure of Clopidogrel therapy.

Med Hypotheses. 2006;67(1):200-1. doi: 10.1016/j.mehy.2006.01.010. Epub 2006 Feb 28.

A double-blind, randomized study on platelet aggregation in patients treated with a daily dose of 150 or 75 mg of clopidogrel for 30 days.

Eur Heart J. 2007 Aug;28(15):1814-9. doi: 10.1093/eurheartj/ehl489. Epub 2007 Feb 1.

Clopidogrel resistance.

Heart Lung Circ. 2007;16 Suppl 3:S17-28. doi: 10.1016/j.hlc.2007.03.012. Epub 2007 Jul 3.

Evaluation of clopidogrel resistance.

Thromb Res. 2005;116(5):451-3. doi: 10.1016/j.thromres.2005.05.017.

Platelet response to clopidogrel is attenuated in diabetic patients undergoing coronary stent implantation.

Diabetes Care. 2007 Feb;30(2):372-4. doi: 10.2337/dc06-1625.